Session Information
-
WCLC 2018
19th World Conference on Lung Cancer
Conference Program for the 19th World Conference on Lung Cancer in Toronto, Canada
Download PDF of the Abstract Book: Click Here.
Presentation Date(s):- Sept 23 - 26, 2018
- Total Presentations: 2391
September 23 Sun
Sep 23 Monday
September 24 Mon
Sep 24 Tuesday
September 25 Tue
Sep 25 Wednesday
September 26 Wed
Sep 26
-
+
MS18 - Management of SCLC Patients Not Represented in Clinical Trials
- 13:30 - 15:00
- 9/25/2018
- Location: Room 206 BD
- Type: Mini Symposium
- Track: Small Cell Lung Cancer/NET
-
+
MS18.01 - Treatment of Patients with Poor Performance Status (ECOG 3-4)
13:30 - 13:50 | Presenter: Luiz H. Araujo
- Abstract
No abstract available for this presentation
-
+
MS18.02 - Treatment of Elderly Patients with SCLC
13:50 - 14:10 | Presenter: Karen Kelly
- Abstract
No abstract available for this presentation
-
+
MS18.03 - Treatment of SCLC transformed from EGFR Mutant Adenocarcinoma
14:10 - 14:30 | Presenter: Nicolas Marcoux
- Abstract
No abstract available for this presentation
-
+
MS18.04 - Retreatment with Platinum and Etoposide and Treatment Beyond Second Line
14:30 - 14:50 | Presenter: Charles Butts
- Abstract
No abstract available for this presentation
-
+
MS18.05 - Q&A
14:50 - 15:00
- Abstract
No abstract available for this presentation
-
+
MS19 - Pulmonary Dilemmas with Immunotherapy
- 13:30 - 15:00
- 9/25/2018
- Location: Room 201 BD
- Type: Mini Symposium
- Track: Interventional Diagnostics/Pulmonology
-
+
MS19.01 - Drug-Induced Pneumonitis with IO: How worried should we be for our Lung Cancer Patients
13:30 - 13:50 | Presenter: Desiree Hao
- Abstract
No abstract available for this presentation
-
+
MS19.02 - What Are the Clinical Features of IO Progression/Pseudoprogression and Radiation Fibrosis vs Recurrence
13:50 - 14:10 | Presenter: Chong-Kin Liam
- Abstract
No abstract available for this presentation
-
+
MS19.03 - Diagnostic Approaches Suspected IO Progression/Pseudoprogression and What/When to Rebiospy for TT Progression
14:10 - 14:30 | Presenter: Kasia Czarnecka-Kujawa
- Abstract
No abstract available for this presentation
-
+
MS19.04 - Q&A
14:30 - 15:00
- Abstract
No abstract available for this presentation
-
+
OA11 - Thymic and Other Thoracic Tumours: Targeted Therapies, Biomarkers and Neo/Adjuvant Radiotherapy
- 13:30 - 15:00
- 9/25/2018
- Location: Room 205 BD
- Type: Oral Abstract Session
- Track: Thymoma/Other Thoracic Malignancies
-
+
OA11.01 - Role of Post-Operative Radiation in Different Histologic Subgroups of Thymoma: Result Based on National Cancer Data Base (NCDB)
13:30 - 13:40 | Presenter: Tithi Biswas | Author(s): Asoke Dey, Tarun Podder
- Abstract
Loading... -
+
OA11.02 - A Population-Based Study of Incidence and Survival Trends of 1,588 Thymic Malignancies: Results from the California Cancer Registry
13:40 - 13:50 | Presenter: David Joseph Benjamin | Author(s): Amy Klapheke, Primo Lara, Rosemary Cress, Jonathan W Riess
- Abstract
Loading... -
+
OA11.03 - Discussant - OA 11.01, OA 11.02
13:50 - 14:05 | Presenter: Andrew Hope
- Abstract
No abstract available for this presentation
-
+
OA11.04 - A Comparative Study of PD-L1 Immunohistochemical Assays with Four Reliable Antibodies in Thymic Carcinoma
14:05 - 14:15 | Presenter: Tadashi Sakane | Author(s): Hiroshi Haneda, Katsuhiro Okuda, Keisuke Yokota, Tsutomu Tatematsu, Risa Oda, Takuya Watanabe, Yushi Saito, Takeshi Yamada, Ryoichi Nakanishi
- Abstract
Loading... -
+
OA11.05 - Phase II Study of Sunitinib in Patients with Thymic Carcinoma Previously Treated with Platinum-Based Chemotherapy (KOSMIC Trial)
14:15 - 14:25 | Presenter: Se Hyun Kim | Author(s): Yu Jung Kim, Chan-Young Ock, Miso Kim, Bhumsuk Keam, Tae Min Kim, Dong-Wan Kim, Dae Seog Heo, Jong Seok Lee
- Abstract
Loading... -
+
OA11.06 - Two BRM Promoter Polymorphisms Do Not Predict Susceptibility or Prognosis of Thymoma
14:25 - 14:35 | Presenter: Nathan Kuehne | Author(s): Min Joon Lee, Katrina Hueniken, Daniel Shepshelovich, Sara Victoria Soldera, Sharara Shakik, Devalben Patel, Dangxiao Cheng, Zhuo Chen, Lawson Eng, M Catherine Brown, Andrea Bezjak, Shaf Keshavjee, David Reisman, Wei Xu, Geoffrey Liu
- Abstract
Loading... -
+
OA11.07 - Discussant - OA 11.04, OA 11.05, OA 11.06
14:35 - 14:50 | Presenter: Giuseppe Giaccone
- Abstract
No abstract available for this presentation
-
+
OA11.08 - Q&A
14:50 - 15:00
- Abstract
No abstract available for this presentation
-
+
PC06 - Controversies in Immunobiomarker Testing
- 13:30 - 15:00
- 9/25/2018
- Location: Room 106
- Type: Pro-Con Session
- Track: Pathology
-
+
PC06.01 - Laboratory Developed Test - PRO
13:30 - 13:50 | Presenter: Dara L. Aisner
- Abstract
No abstract available for this presentation
-
+
PC06.02 - Laboratory Developed Test - CON
13:50 - 14:10 | Presenter: Mari Mino-Kenudson
- Abstract
No abstract available for this presentation
-
+
PC06.03 - Tumor Mutation Burden - PRO
14:10 - 14:30 | Presenter: Lynette M Sholl
- Abstract
No abstract available for this presentation
-
+
PC06.04 - Tumor Mutation Burden - CON
14:30 - 14:50 | Presenter: Lukas Bubendorf
- Abstract
No abstract available for this presentation
-
+
PC06.05 - Q&A
14:50 - 15:00
- Abstract
No abstract available for this presentation
-
+
PC07 - The Future of Cytotoxic Chemotherapy in Advanced NSCLC
- 13:30 - 15:00
- 9/25/2018
- Location: Room 202 BD
- Type: Pro-Con Session
- Track: Advanced NSCLC
-
+
PC07.01 - Debate 2: Chemotherapy Will Become a Thing of the Past in the Management of Advanced NSCLC - For
14:10 - 14:30 | Presenter: Suresh S. Ramalingam
- Abstract
No abstract available for this presentation
-
+
PC07.02 - Debate 2: Chemotherapy Will Become a Thing of the Past in the Management of Advanced NSCLC - Against
14:30 - 14:50 | Presenter: Keunchil Park
- Abstract
No abstract available for this presentation
-
+
PC07.03 - Debate 1: For Wild-Type NSCLC, Which Will Be the Preferred Strategy: IO Alone versus Chemo + IO - IO Alone
13:30 - 13:50 | Presenter: Leora Horn
- Abstract
No abstract available for this presentation
-
+
PC07.04 - Debate 1: For Wild-Type NSCLC, Which Will Be the Preferred Strategy: IO Alone versus Chemo + IO - Chemo + IO
13:50 - 14:10 | Presenter: Federico Cappuzzo
- Abstract
No abstract available for this presentation
-
+
PC07.05 - Q&A
14:50 - 15:00
- Abstract
No abstract available for this presentation
-
+
PC08 - The Great Oligometastatic Debates
- 13:30 - 15:00
- 9/25/2018
- Location: Room 105
- Type: Pro-Con Session
- Track: Oligometastatic NSCLC
-
+
PC08.01 - Debate #1: Locally Ablative Therapies Should Be Standard Treatment for Patients with NSCLC Oligometastese (PRO)
13:30 - 13:40 | Presenter: Howard West
- Abstract
No abstract available for this presentation
-
+
PC08.02 - Debate #1: Locally Ablative Therapies Should Be Standard Treatment for Patients with NSCLC Oligometastese (CON)
13:40 - 13:50 | Presenter: Puneeth Iyengar
- Abstract
No abstract available for this presentation
-
+
PC08.03 - Discussion
13:50 - 14:00
- Abstract
No abstract available for this presentation
-
+
PC08.04 - Debate #2: Optimal Therapy for OM Disease: Thoracic Surgery Should Be the Treatment of Choice Whenever Possible
14:00 - 14:10 | Presenter: David R. Jones
- Abstract
No abstract available for this presentation
-
+
PC08.05 - Debate #2: Keep Calm and Beam On: Thoracic Radiation Obviates the Need for Surgery
14:10 - 14:20 | Presenter: Matthias Guckenberger
- Abstract
No abstract available for this presentation
-
+
PC08.06 - Discussion
14:20 - 14:30
- Abstract
No abstract available for this presentation
-
+
PC08.07 - Debate #3: Brain Metastases with a Driver Mutation Should Be Treated with Systemic Therapy First (PRO)
14:30 - 14:40 | Presenter: Mark K. Doherty
- Abstract
No abstract available for this presentation
-
+
PC08.08 - Debate #3: Brain Metastases with a Driver Mutation Should Be Treated with Systemic Therapy First (CON)
14:40 - 14:50 | Presenter: Marta Scorsetti
- Abstract
No abstract available for this presentation
-
+
PC08.09 - Discussion
14:50 - 15:00
- Abstract
No abstract available for this presentation
-
+
ES03 - How to Manage Pleural Plaques and Pleural Effusion with Negative Pleural Biopsy
- 15:15 - 16:45
- 9/25/2018
- Location: Room 206 AC
- Type: Educational Session
- Track: Mesothelioma
-
+
ES03.01 - Diagnosis of Mesothelioma Based on Cytology Alone
15:15 - 15:30 | Presenter: Jennifer Sauter
- Abstract
No abstract available for this presentation
-
+
ES03.02 - Role of CT Scan to Follow Pleural Plaques
15:30 - 15:45 | Presenter: Demetris Patsios
- Abstract
No abstract available for this presentation
-
+
ES03.03 - When to Repeat Pleural Biopsies
15:45 - 16:00 | Presenter: Catherine Labbe
- Abstract
No abstract available for this presentation
-
+
ES03.04 - Role of Chemotherapy in Mesothelioma with Minimal Bulk Disease
16:00 - 16:15 | Presenter: Christopher W. Lee
- Abstract
No abstract available for this presentation
-
+
ES03.05 - Role of Surgery in T0 Mesothelioma
16:15 - 16:30 | Presenter: Seiki Hasegawa | Author(s): Hiroshi Kodama, Masaki Hashimoto, Akihiro Fukuda, Toru Nakamichi, Akifumi Nakamura, Ayumi Kuroda, Teruhisa Takuwa, Seiji Matsumoto, Yoshitomo Okumura, Koichiro Yamakado, Takashi Kijima, Nobuyuki Kondo
- Abstract
No abstract available for this presentation
-
+
ES03.06 - Q&A
16:30 - 16:45
- Abstract
No abstract available for this presentation
-
+
ES04 - Liquid Biopsies in Lung Cancer
- 15:15 - 16:45
- 9/25/2018
- Location: Room 203 BD
- Type: Educational Session
- Track: Targeted Therapy
-
+
ES04.00 - Introduction with Poll Questions
15:15 - 15:20 | Presenter: Sai-Hong Ignatius Ou, Ignacio I. Wistuba
- Abstract
No abstract available for this presentation
-
+
ES04.01 - Liquid Biopsies in Lung Cancer
15:20 - 15:40 | Presenter: Ming Sound Tsao
- Abstract
No abstract available for this presentation
-
+
ES04.02 - Mechanisms of Resistance to Targeted Therapy
15:40 - 16:00 | Presenter: Christine Lovly
- Abstract
No abstract available for this presentation
-
+
ES04.03 - Overcoming Resistance by Improving Treatment Compliance
16:00 - 16:20 | Presenter: Felipe Gomes
- Abstract
No abstract available for this presentation
-
+
ES04.04 - Guiding Second Line Treatment in ALK + Patients (Sequence of Drugs, Rebiopsy?)
16:20 - 16:40 | Presenter: Enriqueta Felip
- Abstract
No abstract available for this presentation
-
+
ES04.05 - Q&A
16:40 - 16:45
- Abstract
No abstract available for this presentation
-
+
ES05 - Collaboration Between Stakeholders to Improve Lung Cancer Research
- 15:15 - 16:45
- 9/25/2018
- Location: Room 205 AC
- Type: Educational Session
- Track: Advocacy
-
+
ES05.01 - Linking the Stakeholders: Can Patient Groups, Clinical Researchers and the Pharmaceutical Industry Collaborate to Accelerate Research?
15:15 - 15:35 | Presenter: Janet Freeman-Daily
- Abstract
No abstract available for this presentation
-
+
ES05.02 - Can Patient Groups and Regulatory Bodies Work Together to Make Clinical Research Easier?
15:35 - 15:55 | Presenter: Andrea Ferris
- Abstract
No abstract available for this presentation
-
+
ES05.03 - Discrepancies and Sustainable Access to Innovative Therapies: Transforming Patient Experience in to Patient Voice
15:55 - 16:15 | Presenter: Jesme Fox
- Abstract
No abstract available for this presentation
-
+
ES05.04 - Challenges and Solutions in Engaging with the Health Technology Assessment Process in Canada
16:15 - 16:35 | Presenter: Christina Sit
- Abstract
No abstract available for this presentation
-
+
ES05.05 - Q&A
16:35 - 16:45
- Abstract
No abstract available for this presentation
-
+
GR02 - Management of N2 NSCLC - A Case Based Discussion
- 15:15 - 16:45
- 9/25/2018
- Location: Room 107
- Type: Grand Rounds Session
- Track: Treatment of Locoregional Disease - NSCLC
-
+
GR02.01 - Case 1: Single Zone N2 (No Pneumonectomy Necessary)
15:15 - 15:25 | Presenter: Anna Wrona
- Abstract
No abstract available for this presentation
-
+
GR02.02 - Panel Discussion
15:25 - 15:45 | Presenter: David Harpole, Hiroshi Date, Alexander Sun, Joop de Langen, Mary Duffy, Kathy S. Albain
- Abstract
No abstract available for this presentation
-
+
GR02.03 - Case 2: Multiple N2 Bulky Primary
15:45 - 15:55 | Presenter: Megan Eileen Daly
- Abstract
No abstract available for this presentation
-
+
GR02.04 - Panel Discussion
15:55 - 16:15 | Presenter: David Harpole, Hiroshi Date, Alexander Sun, Joop de Langen, Mary Duffy, Kathy S. Albain
- Abstract
No abstract available for this presentation
-
+
GR02.05 - Case 3: Post Operative Management of Incidentally Found N2 Disease
16:15 - 16:25 | Presenter: Masaya Yotsukura
- Abstract
No abstract available for this presentation
-
+
GR02.06 - Panel Discussion
16:25 - 16:45 | Presenter: David Harpole, Hiroshi Date, Alexander Sun, Joop de Langen, Mary Duffy, Kathy S. Albain
- Abstract
No abstract available for this presentation
first
prev
